Ann Arbor VA Safety Policies - VA Ann Arbor Healthcare System Research Services
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

VA Ann Arbor Healthcare System Research Services

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
 

Ann Arbor VA Safety Policies

Every initial protocol submission (human, animal, and laboratory) in AAROW includes a Research Safety Hazard Assessment Survey.  If the protocol uses any of the following, AAROW brings them to Laboratory Safety Hazard Assessment Form which is reviewed by the Research Subcommittee on Research Safety:

  • human tissues
  • ionizing radiation
  • biological agents
  • chemicals
  • recombinant DNA (will be reviewed by the University of Michigan Institutional Biosafety Committee)
  • non-human tissues
  • physical agents (e.g. UV light, electricity)
  • animals (must also complete the ACORP)
  • controlled substances

The Committee is comprised of researchers, scientists, the Veterinary Medical Unit supervisor, the facility Radiation Safety Officer and the facility Industrial Hygiene Officer. It meets most months (as needed), generally on the third Thursday. The Principal Investigator should provide the SRS Coordinator with a complete and signed Research Protocol Safety Evaluation specific to the research being conducted a minimum of 7 working days prior to an SRS meeting in order to be reviewed at that meeting. Include: a Chemical Inventory, any additional approval letters (RSC or IBC), and proof of DOT training (if shipping).

Once the SRS reviews the Initial Safety application, 3 outcomes are possible:

  • –Approved – No issues identified, no follow-up required.
  • Approved Pending Modifications- Revisions are requested but are considered minor enough that they don’t require full committee to see them again. If contingencies are satisfied through a designated member review, approval will be granted. –
  • –Withhold approval – Numerous or significant issues that cannot be resolved during the SRS meeting, which are communicated to the investigator. PI response requires full committee consideration for approval. Response will be placed on the next regularly scheduled meeting agenda.

All outcomes will be communicated to the Investigator by the SRS Coordinator in a timely manner. The SRS is also responsible for conducting annual review and oversight of all studies with potential safety hazards and coordination of safety-related activities in research laboratories including mandatory and non-mandatory training, safety inspections, accident reporting, and liaison activities with facility safety committees and officials as required in VHA Directive 1200.08.

For more information, refer to Guidance Documents and Resources and Policies.


Please contact Melonie Wissing with any questions regarding use of radiation.

Please contact Carolyn Slusher, the Safety Coordinator, with all other questions.

Printed copies of the policies are available in these locations:
Bldg 22--Room G19a (Research Library/Conference room)
Bldg 31--Room 204 (Research Conference room)